Skip to content

A Comparison of Short-Term Treatment Effects of Intravenous Sodium Amytal-Methedrine and LSD in the Alcoholic

F.G. Johnson

Canadian Psychiatric Association Journal October 1, 1970 DOI: 10.1177/070674377001500514 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Comparative clinical study Peer reviewed
Population Patients with alcoholism
Interventions Lysergic acid diethylamide (L.S.D.) sodium amylobarbitone-methedrine (S.A.M.)
Duration One-year follow-up
Topics LSD
Citations 3
Key points L.S.D. produced a different quality of response from S.A.M. across somatic, cognitive, and affective experiences, but about half of patients in all categories reported a pronounced reduction of tension and depression afterward. At one year, however, neither drug yielded a significantly greater improvement rate than routine clinic treatment.

Abstract

Lysergic acid diethylamide (L.S.D.), given with and without a therapist present, is compared with sodium amylobarbitone-methedrine (S.A.M.), given with á therapist present, as abreactive agents in the treatment of alcoholism. Somatic, cognitive and affective experiences under the different treatment conditions are compared. L.S.D. produced a different quality of response from S.A.M. in many respects, but approximately half the patients in all categories noted a pronounced reduction of tension and depression following the experience. This short-term effect is contrasted with long-term (one year) absence of a significantly greater improvement rate with these drugs than with routine clinic treatment. The significance of these findings is discussed.

Citations in the library

Explore topics